Fulgent Genetics (FLGT) Other Non-Current Liabilities (2016 - 2026)
Fulgent Genetics' Other Non-Current Liabilities history spans 10 years, with the latest figure at $9.4 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 53.09% to $9.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $9.4 million, a 53.09% increase, with the full-year FY2025 number at $7.6 million, up 2017.78% from a year prior.
- Other Non-Current Liabilities hit $9.4 million in Q1 2026 for Fulgent Genetics, up from $7.6 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for FLGT hit a ceiling of $20.0 million in Q3 2022 and a floor of $182000.0 in Q2 2025.
- Historically, Other Non-Current Liabilities has averaged $8.3 million across 5 years, with a median of $6.3 million in 2024.
- Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 2415.17% in 2022 and later plummeted 96.17% in 2025.
- Tracing FLGT's Other Non-Current Liabilities over 5 years: stood at $18.2 million in 2022, then crashed by 67.22% to $6.0 million in 2023, then crashed by 93.98% to $360000.0 in 2024, then soared by 2017.78% to $7.6 million in 2025, then increased by 22.93% to $9.4 million in 2026.
- Business Quant data shows Other Non-Current Liabilities for FLGT at $9.4 million in Q1 2026, $7.6 million in Q4 2025, and $2.0 million in Q3 2025.